Affinity Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Affinity Capital Advisors's AMGN Position: Q2 2026 in Review
Affinity Capital Advisors reduced its Amgen (AMGN) stake by 5.2% in Q2 2026, selling an estimated $18.1K and leaving 964 shares worth $353K. The position accounts for 0.04% of the portfolio, ranked #131.
Affinity Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 19 quarters since. The position peaked at $358K in Q1 2026. 575 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Affinity Capital Advisors held 964 shares of Amgen worth $353K as of Q2 2026.
- Affinity Capital Advisors sold 53 Amgen shares in Q2 2026, an estimated $18.1K.
- Amgen made up 0.04% of Affinity Capital Advisors's portfolio in Q2 2026, its #131 holding.
- Affinity Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 19 quarters since.
- Affinity Capital Advisors's Amgen position peaked at $358K in Q1 2026.
- 575 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.